Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-10-05 17:57:59
Reporting Period:
Accepted Time:
2017-10-05 17:57:59
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1016169 Antares Pharma Inc. ATRS Surgical & Medical Instruments & Apparatus (3841) 411350192
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1275012 J Thomas Garrity C/o Antares Pharma, Inc.
100 Princeton South, Suite 300
Ewing NJ 08628
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-10-03 30,000 $0.85 190,213 No 4 M Direct
Common Stock Disposition 2017-10-03 30,000 $3.50 160,213 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2017-10-03 30,000 $0.00 30,000 $0.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-05-13 No 4 M Direct
  1. The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted in September 2016.
  2. The options vested and became exercisable in four equal quarterly installments following the grant date of May 14, 2008.